BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE

BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE was reported 10705 times

BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSTNATAL GROWTH RESTRICTION 15 0.1145
1 MEDICATION OVERUSE HEADACHE 22 0.0257
2 ANION GAP 16 0.0252
3 INTRACRANIAL VENOUS SINUS THROMBOSIS 20 0.0187
4 TRANSVERSE SINUS THROMBOSIS 9 0.0171
5 GESTATIONAL HYPERTENSION 18 0.0139
6 PRE-EXISTING CONDITION IMPROVED 76 0.0122
7 INFUSION SITE IRRITATION 14 0.0109
8 INFUSION SITE DISCHARGE 18 0.0103
9 INFUSION SITE DISCOMFORT 9 0.0087
10 COSTOCHONDRITIS 14 0.0086
11 ARNOLD-CHIARI MALFORMATION 8 0.0084
12 PRETERM PREMATURE RUPTURE OF MEMBRANES 10 0.0083
13 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 11 0.0081
14 INFUSION SITE HAEMORRHAGE 26 0.0079
15 MIGRAINE 743 0.0078
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
17 INFUSION SITE PRURITUS 23 0.0073
18 TORTICOLLIS 15 0.0071
19 CATAPLEXY 10 0.0071
20 CHOLECYSTITIS CHRONIC 47 0.0070
21 DEVICE INFUSION ISSUE 17 0.0068
22 COLONIC POLYP 11 0.0067
23 BILIARY DYSKINESIA 11 0.0065
24 CERVICAL SPINAL STENOSIS 11 0.0064
25 INFUSION SITE SWELLING 39 0.0062
26 COMPLEX REGIONAL PAIN SYNDROME 9 0.0061
27 INFUSION SITE INDURATION 9 0.0061
28 INFUSION SITE BRUISING 13 0.0060
29 CHRONIC FATIGUE SYNDROME 8 0.0057
30 FLAT AFFECT 13 0.0056
31 INFUSION SITE PAIN 72 0.0056
32 PRE-ECLAMPSIA 26 0.0055
33 CATHETER SITE PAIN 14 0.0054
34 CATHETER SITE ERYTHEMA 11 0.0051
35 FEAR OF DISEASE 9 0.0051
36 JUGULAR VEIN THROMBOSIS 9 0.0051
37 INFUSION SITE ERYTHEMA 42 0.0050
38 ESSENTIAL HYPERTENSION 9 0.0049
39 MIGRAINE WITH AURA 13 0.0048
40 TENSION HEADACHE 20 0.0046
41 CONCUSSION 36 0.0046
42 GESTATIONAL DIABETES 22 0.0046
43 NASAL SEPTUM DEVIATION 9 0.0046
44 NEPHROGENIC ANAEMIA 21 0.0045
45 TEMPOROMANDIBULAR JOINT SYNDROME 12 0.0045
46 NECK INJURY 13 0.0044
47 INFUSION SITE REACTION 13 0.0043
48 CEREBROSPINAL FLUID LEAKAGE 8 0.0043
49 POST-TRAUMATIC STRESS DISORDER 29 0.0043
50 SPINAL OSTEOARTHRITIS 38 0.0043
51 INFUSION SITE INFECTION 10 0.0043
52 AURA 8 0.0043
53 EYE CONTUSION 9 0.0043
54 PREMATURE LABOUR 24 0.0042
55 SINUS OPERATION 10 0.0042
56 CLUMSINESS 11 0.0040
57 MENINGITIS ASEPTIC 18 0.0040
58 INTERVERTEBRAL DISC DISORDER 16 0.0037
59 SNORING 14 0.0037
60 SEASONAL ALLERGY 51 0.0036
61 SPINAL COLUMN STENOSIS 17 0.0036
62 HYPERPARATHYROIDISM SECONDARY 9 0.0036
63 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
64 FIBROMYALGIA 82 0.0034
65 ALCOHOL ABUSE 9 0.0034
66 SLEEP APNOEA SYNDROME 64 0.0034
67 SOMNAMBULISM 22 0.0033
68 INTERVERTEBRAL DISC DEGENERATION 31 0.0033
69 CRANIOCEREBRAL INJURY 10 0.0033
70 PATENT DUCTUS ARTERIOSUS 13 0.0033
71 CHRONIC SINUSITIS 12 0.0032
72 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
73 MAJOR DEPRESSION 23 0.0031
74 BILIARY COLIC 9 0.0031
75 VASCULAR DEVICE INFECTION 14 0.0031
76 DERMATITIS CONTACT 35 0.0031
77 SCOLIOSIS 19 0.0031
78 MULTIPLE ALLERGIES 24 0.0031
79 ANEURYSM 15 0.0030
80 BLOOD POTASSIUM ABNORMAL 8 0.0030
81 LYME DISEASE 10 0.0030
82 LIVE BIRTH 25 0.0030
83 MATERNAL EXPOSURE TIMING UNSPECIFIED 11 0.0029
84 VITAMIN D DECREASED 25 0.0029
85 INFUSION SITE EXTRAVASATION 18 0.0029
86 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
87 ATRIAL SEPTAL DEFECT 24 0.0029
88 BIPOLAR DISORDER 31 0.0028
89 DRUG TOLERANCE DECREASED 8 0.0028
90 HANGOVER 10 0.0028
91 FEELING DRUNK 21 0.0028
92 CEREBRAL THROMBOSIS 8 0.0028
93 APPENDICECTOMY 10 0.0028
94 SUSPECTED SUICIDE 13 0.0028
95 FACIAL PAIN 24 0.0027
96 PARTIAL SEIZURES 14 0.0027
97 BACK INJURY 29 0.0027
98 VITAMIN D DEFICIENCY 26 0.0027
99 PHOTOPHOBIA 50 0.0027
100 AUTOIMMUNE THYROIDITIS 10 0.0026
101 FOOT FRACTURE 50 0.0026
102 SELF-INJURIOUS IDEATION 11 0.0026
103 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
104 DECREASED INTEREST 15 0.0025
105 HAND FRACTURE 18 0.0025
106 SINUSITIS 257 0.0025
107 FACIAL BONES FRACTURE 9 0.0025
108 HOMICIDAL IDEATION 10 0.0025
109 GALLBLADDER DISORDER 44 0.0025
110 CARDIAC MURMUR 21 0.0024
111 MULTIPLE INJURIES 15 0.0024
112 PAIN IN JAW 67 0.0024
113 PLEURISY 14 0.0024
114 GASTRIC ULCER HAEMORRHAGE 13 0.0023
115 OESOPHAGEAL DISORDER 9 0.0023
116 NECK PAIN 129 0.0023
117 ENDOMETRIOSIS 11 0.0023
118 HYPOPNOEA 8 0.0023
119 THERAPEUTIC RESPONSE UNEXPECTED 103 0.0023
120 INSURANCE ISSUE 35 0.0023
121 RESTLESS LEGS SYNDROME 41 0.0023
122 ECONOMIC PROBLEM 34 0.0022
123 HEREDITARY ANGIOEDEMA 24 0.0022
124 PRODUCT PHYSICAL ISSUE 45 0.0022
125 FUNGAL SKIN INFECTION 9 0.0022
126 TEMPERATURE INTOLERANCE 23 0.0022
127 ENURESIS 9 0.0022
128 FEELING OF BODY TEMPERATURE CHANGE 13 0.0022
129 UPPER RESPIRATORY TRACT INFECTION 102 0.0022
130 ENERGY INCREASED 13 0.0022
131 BLOOD MAGNESIUM DECREASED 19 0.0022
132 COMPLETED SUICIDE 183 0.0022
133 INJURY 154 0.0022
134 EXOSTOSIS 20 0.0022
135 SINUS HEADACHE 13 0.0022
136 FOOD INTOLERANCE 8 0.0022
137 DRUG TOLERANCE 11 0.0022
138 WRIST FRACTURE 26 0.0022
139 THYROID FUNCTION TEST ABNORMAL 9 0.0022
140 HYPOPHOSPHATAEMIA 16 0.0022
141 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
142 HIATUS HERNIA 28 0.0022
143 ARTHROPOD BITE 16 0.0022
144 NERVE INJURY 24 0.0022
145 HYPERACUSIS 8 0.0021
146 SINUS CONGESTION 29 0.0021
147 TRICUSPID VALVE INCOMPETENCE 17 0.0021
148 TOOTH INFECTION 28 0.0021
149 SKIN ABRASION 10 0.0021
150 TENDERNESS 22 0.0021
151 EAR PAIN 41 0.0021
152 ROTATOR CUFF SYNDROME 27 0.0021
153 METABOLIC ACIDOSIS 67 0.0021
154 HYSTERECTOMY 18 0.0021
155 FOOD ALLERGY 16 0.0021
156 ROAD TRAFFIC ACCIDENT 86 0.0021
157 BRONCHITIS 152 0.0021
158 PHARYNGITIS STREPTOCOCCAL 22 0.0020
159 BLOOD POTASSIUM DECREASED 61 0.0020
160 DRUG SCREEN POSITIVE 16 0.0020
161 RHINITIS ALLERGIC 9 0.0020
162 IRON DEFICIENCY 9 0.0020
163 HEADACHE 1250 0.0020
164 IMPAIRED GASTRIC EMPTYING 27 0.0020
165 SINUS DISORDER 39 0.0020
166 EYELID PTOSIS 20 0.0020
167 INCREASED TENDENCY TO BRUISE 18 0.0020
168 EAR INFECTION 52 0.0020
169 INITIAL INSOMNIA 20 0.0019
170 ANKLE FRACTURE 30 0.0019
171 BREAST MASS 13 0.0019
172 PERONEAL NERVE PALSY 11 0.0019
173 NEURALGIA 47 0.0019
174 PELVIC FRACTURE 15 0.0019
175 CHOLECYSTECTOMY 22 0.0019
176 MUSCLE TIGHTNESS 31 0.0019
177 ANHEDONIA 50 0.0019
178 OVARIAN CYST 19 0.0019
179 EYE MOVEMENT DISORDER 13 0.0019
180 CANDIDA INFECTION 32 0.0019
181 NASAL DISCOMFORT 15 0.0019
182 BUNDLE BRANCH BLOCK LEFT 8 0.0019
183 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
184 CARDIOMEGALY 23 0.0019
185 DECREASED ACTIVITY 20 0.0019
186 IMPAIRED DRIVING ABILITY 21 0.0018
187 DIVERTICULUM INTESTINAL 8 0.0018
188 WOUND INFECTION 20 0.0018
189 HYPERVOLAEMIA 9 0.0018
190 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
191 TOOTH FRACTURE 20 0.0018
192 SCAR 31 0.0018
193 CATHETERISATION CARDIAC 8 0.0018
194 HEAD INJURY 57 0.0018
195 JOINT DISLOCATION 19 0.0018
196 STREPTOCOCCAL INFECTION 10 0.0018
197 MENINGITIS 12 0.0018
198 MENISCUS INJURY 11 0.0018
199 EMPHYSEMA 18 0.0018
200 HYPERSOMNIA 51 0.0018
201 DYSPHORIA 9 0.0018
202 PHARYNGITIS 22 0.0018
203 GINGIVAL PAIN 14 0.0018
204 ECCHYMOSIS 12 0.0017
205 CARDIAC VALVE DISEASE 10 0.0017
206 TRANSIENT ISCHAEMIC ATTACK 59 0.0017
207 PERIPHERAL COLDNESS 24 0.0017
208 BLEPHAROSPASM 11 0.0017
209 TRISMUS 9 0.0017
210 VARICOSE VEIN 9 0.0017
211 NERVE COMPRESSION 16 0.0017
212 MALABSORPTION 9 0.0017
213 DEPRESSION 391 0.0017
214 CARPAL TUNNEL SYNDROME 24 0.0017
215 ARTERIOSCLEROSIS 16 0.0017
216 HAIR DISORDER 14 0.0017
217 TINNITUS 78 0.0017
218 OBESITY 27 0.0017
219 GASTROOESOPHAGEAL REFLUX DISEASE 136 0.0017
220 SPINAL DISORDER 16 0.0017
221 HAIR COLOUR CHANGES 21 0.0017
222 FOOD POISONING 9 0.0017
223 IRRITABLE BOWEL SYNDROME 36 0.0017
224 CENTRAL NERVOUS SYSTEM LESION 23 0.0017
225 GASTROENTERITIS VIRAL 30 0.0017
226 VISUAL FIELD DEFECT 12 0.0017
227 AMNESIA 108 0.0017
228 TONGUE DISORDER 12 0.0017
229 EAR DISCOMFORT 17 0.0017
230 ATELECTASIS 16 0.0017
231 DIPLOPIA 43 0.0017
232 ENTEROCOCCAL INFECTION 8 0.0017
233 SKIN LACERATION 18 0.0017
234 UTERINE PERFORATION 14 0.0017
235 HUNGER 23 0.0016
236 RESPIRATORY TRACT INFECTION 43 0.0016
237 OSTEOPENIA 25 0.0016
238 MASS 23 0.0016
239 HAIR TEXTURE ABNORMAL 22 0.0016
240 FAECALOMA 9 0.0016
241 RESPIRATORY DEPRESSION 20 0.0016
242 RENAL TUBULAR NECROSIS 16 0.0016
243 OSTEOARTHRITIS 69 0.0016
244 DENTAL CARIES 18 0.0016
245 DRUG ABUSER 10 0.0016
246 SMALL INTESTINAL OBSTRUCTION 20 0.0016
247 APPLICATION SITE BURN 8 0.0016
248 CEREBRAL DISORDER 12 0.0016
249 HEPATOTOXICITY 36 0.0016
250 CHOLELITHIASIS 53 0.0016
251 DEEP VEIN THROMBOSIS 105 0.0016
252 MALNUTRITION 18 0.0016
253 INCONTINENCE 17 0.0016
254 POST PROCEDURAL INFECTION 13 0.0016
255 PELVIC PAIN 29 0.0016
256 PARAESTHESIA ORAL 23 0.0016
257 EYE INFECTION 18 0.0016
258 BODY HEIGHT DECREASED 17 0.0016
259 HAEMORRHOIDS 31 0.0016
260 FORMICATION 11 0.0016
261 MUSCULOSKELETAL DISCOMFORT 27 0.0016
262 POST PROCEDURAL COMPLICATION 30 0.0016
263 MUSCLE TWITCHING 36 0.0016
264 INCREASED UPPER AIRWAY SECRETION 8 0.0016
265 RIB FRACTURE 32 0.0016
266 BACK PAIN 360 0.0015
267 RETCHING 33 0.0015
268 POOR VENOUS ACCESS 16 0.0015
269 LIMB INJURY 42 0.0015
270 JOINT INJURY 33 0.0015
271 FAILURE TO THRIVE 8 0.0015
272 CHEST PAIN 285 0.0015
273 BALANCE DISORDER 133 0.0015
274 BACK DISORDER 25 0.0015
275 VIRAL INFECTION 51 0.0015
276 WEIGHT FLUCTUATION 16 0.0015
277 HEAD DISCOMFORT 27 0.0015
278 ANXIETY 433 0.0015
279 NIGHT SWEATS 49 0.0015
280 IMMUNE SYSTEM DISORDER 20 0.0015
281 IRON DEFICIENCY ANAEMIA 14 0.0015
282 DYSARTHRIA 57 0.0015
283 CRYING 55 0.0015
284 THIRST 27 0.0015
285 RESPIRATORY TRACT CONGESTION 24 0.0015
286 APPETITE DISORDER 10 0.0015
287 COAGULOPATHY 25 0.0015
288 NEPHROPATHY 14 0.0015
289 SENSORY LOSS 12 0.0015
290 GINGIVITIS 8 0.0015
291 NEPHROLITHIASIS 68 0.0015
292 PANIC ATTACK 54 0.0015
293 HEMIPARESIS 25 0.0015
294 HYPOAESTHESIA 220 0.0015
295 MADAROSIS 17 0.0015
296 SPINAL OPERATION 18 0.0015
297 CARDIO-RESPIRATORY ARREST 61 0.0015
298 PLATELET COUNT INCREASED 19 0.0015
299 ASTHENOPIA 8 0.0015
300 GASTROINTESTINAL PAIN 16 0.0015
301 CHOKING SENSATION 8 0.0014
302 GASTROINTESTINAL INFECTION 13 0.0014
303 THINKING ABNORMAL 27 0.0014
304 LYMPHOEDEMA 10 0.0014
305 VENTRICULAR EXTRASYSTOLES 15 0.0014
306 PREMATURE DELIVERY 23 0.0014
307 INJECTION SITE DISCOLOURATION 18 0.0014
308 BLOOD CHOLESTEROL INCREASED 67 0.0014
309 FEELING ABNORMAL 344 0.0014
310 SUICIDAL IDEATION 131 0.0014
311 SENSATION OF FOREIGN BODY 12 0.0014
312 ACCIDENT 17 0.0014
313 FEELING JITTERY 27 0.0014
314 MITRAL VALVE INCOMPETENCE 16 0.0014
315 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
316 PULMONARY MASS 21 0.0014
317 ADRENAL INSUFFICIENCY 17 0.0014
318 BRAIN INJURY 14 0.0014
319 EMOTIONAL DISORDER 43 0.0014
320 VERTIGO 85 0.0014
321 INCOHERENT 9 0.0014
322 PSYCHOLOGICAL TRAUMA 12 0.0014
323 EXERCISE TOLERANCE DECREASED 8 0.0014
324 MUSCLE STRAIN 12 0.0014
325 INSOMNIA 369 0.0014
326 TENDON DISORDER 9 0.0014
327 HYPERVENTILATION 8 0.0014
328 FUNGAL INFECTION 46 0.0014
329 COMPLICATION ASSOCIATED WITH DEVICE 20 0.0014
330 PULMONARY THROMBOSIS 15 0.0014
331 MULTIPLE SCLEROSIS RELAPSE 94 0.0014
332 CONTUSION 132 0.0014
333 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
334 BLOOD CALCIUM INCREASED 12 0.0014
335 OSTEOPOROSIS 56 0.0014
336 PULMONARY EMBOLISM 129 0.0014
337 SUBSTANCE ABUSE 11 0.0014
338 BONE PAIN 79 0.0013
339 PARAESTHESIA 211 0.0013
340 HYPERLIPIDAEMIA 16 0.0013
341 MULTIPLE SCLEROSIS 64 0.0013
342 SINUS TACHYCARDIA 19 0.0013
343 INFLUENZA LIKE ILLNESS 110 0.0013
344 COLITIS ISCHAEMIC 9 0.0013
345 MENTAL STATUS CHANGES 37 0.0013
346 OROPHARYNGEAL DISCOMFORT 12 0.0013
347 TOOTHACHE 24 0.0013
348 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 69 0.0013
349 OPTIC NEURITIS 12 0.0013
350 ABNORMAL LOSS OF WEIGHT 9 0.0013
351 LIGAMENT SPRAIN 13 0.0013
352 CELLULITIS 66 0.0013
353 ARTHRITIS 103 0.0013
354 CHRONIC KIDNEY DISEASE 99 0.0013
355 FEAR 35 0.0013
356 POOR QUALITY SLEEP 28 0.0013
357 GRAND MAL CONVULSION 12 0.0013
358 FLUID RETENTION 66 0.0013
359 DRUG DIVERSION 8 0.0013
360 HAEMOLYSIS 10 0.0013
361 PRURITUS GENERALISED 28 0.0013
362 BEDRIDDEN 17 0.0013
363 LIMB DISCOMFORT 40 0.0013
364 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
365 CONGENITAL ANOMALY 10 0.0013
366 FACIAL PARALYSIS 11 0.0013
367 TREMOR 214 0.0013
368 MIDDLE INSOMNIA 24 0.0013
369 APPENDICITIS 12 0.0013
370 DRY THROAT 13 0.0013
371 MUSCULOSKELETAL PAIN 67 0.0013
372 BLOOD SODIUM DECREASED 24 0.0013
373 AFFECTIVE DISORDER 10 0.0013
374 PAIN 780 0.0013
375 JOINT RANGE OF MOTION DECREASED 17 0.0013
376 BLOOD IRON DECREASED 15 0.0013
377 DISTURBANCE IN ATTENTION 68 0.0013
378 HYPOAESTHESIA ORAL 19 0.0013
379 URINARY TRACT INFECTION 215 0.0013
380 NASAL CONGESTION 74 0.0013
381 FALL 419 0.0013
382 EXPOSURE DURING PREGNANCY 78 0.0013
383 DYSKINESIA 51 0.0013
384 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
385 OROPHARYNGEAL PAIN 116 0.0013
386 ILLNESS 129 0.0013
387 AFFECT LABILITY 12 0.0012
388 MOOD ALTERED 34 0.0012
389 SURGERY 73 0.0012
390 HYPERCHOLESTEROLAEMIA 12 0.0012
391 SPEECH DISORDER 65 0.0012
392 DIZZINESS POSTURAL 12 0.0012
393 BURSITIS 15 0.0012
394 NAUSEA 976 0.0012
395 BACTERIAL INFECTION 23 0.0012
396 UTERINE LEIOMYOMA 9 0.0012
397 HERPES SIMPLEX 8 0.0012
398 MEMORY IMPAIRMENT 169 0.0012
399 ORAL DISORDER 9 0.0012
400 DIVERTICULITIS 34 0.0012
401 APHASIA 37 0.0012
402 SOMNOLENCE 246 0.0012
403 HYPOTHYROIDISM 39 0.0012
404 BLINDNESS TRANSIENT 9 0.0012
405 URINARY INCONTINENCE 36 0.0012
406 TENDON RUPTURE 15 0.0012
407 ASTHMA 137 0.0012
408 BLOOD PRESSURE ABNORMAL 24 0.0012
409 END STAGE RENAL DISEASE 22 0.0012
410 ORAL PAIN 27 0.0012
411 CAESAREAN SECTION 14 0.0012
412 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
413 POISONING 15 0.0012
414 MUSCLE SPASMS 219 0.0012
415 PAROSMIA 9 0.0012
416 VISION BLURRED 163 0.0012
417 WEIGHT DECREASED 331 0.0012
418 DEAFNESS 31 0.0012
419 FEEDING DISORDER 24 0.0012
420 TOOTH ABSCESS 12 0.0012
421 GASTRITIS 31 0.0012
422 COGNITIVE DISORDER 55 0.0012
423 INADEQUATE ANALGESIA 10 0.0012
424 DEFORMITY 11 0.0012
425 SLUGGISHNESS 12 0.0012
426 ABDOMINAL PAIN UPPER 242 0.0012
427 BOWEL MOVEMENT IRREGULARITY 9 0.0012
428 CHOLECYSTITIS 14 0.0012
429 MENTAL DISORDER 51 0.0012
430 CHEST DISCOMFORT 120 0.0012
431 ACUTE HEPATIC FAILURE 16 0.0012
432 NERVOUSNESS 61 0.0012
433 DISABILITY 23 0.0012
434 PREMATURE BABY 35 0.0012
435 THROAT IRRITATION 52 0.0012
436 SKIN INFECTION 13 0.0012
437 DYSPEPSIA 114 0.0012
438 GASTRIC ULCER 22 0.0012
439 UPPER LIMB FRACTURE 23 0.0012
440 DIZZINESS 575 0.0012
441 BONE DISORDER 21 0.0012
442 PULMONARY HYPERTENSION 24 0.0012
443 APHONIA 16 0.0011
444 SWELLING 107 0.0011
445 INJECTION SITE URTICARIA 28 0.0011
446 DEPRESSED LEVEL OF CONSCIOUSNESS 45 0.0011
447 HYPERHIDROSIS 146 0.0011
448 RENAL PAIN 12 0.0011
449 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
450 LOSS OF CONSCIOUSNESS 145 0.0011
451 CYSTITIS 36 0.0011
452 DYSSTASIA 33 0.0011
453 INFLUENZA 126 0.0011
454 SCIATICA 18 0.0011
455 CYST 14 0.0011
456 PALPITATIONS 132 0.0011
457 ILEUS 14 0.0011
458 MUSCULAR WEAKNESS 128 0.0011
459 BREAST PAIN 12 0.0011
460 TOOTH EXTRACTION 14 0.0011
461 PHARYNGEAL SWELLING 11 0.0011
462 EMOTIONAL DISTRESS 136 0.0011
463 HEPATOMEGALY 11 0.0011
464 CONVULSION 64 0.0011
465 RHINITIS 9 0.0011
466 SNEEZING 25 0.0011
467 MENTAL IMPAIRMENT 27 0.0011
468 IMPAIRED QUALITY OF LIFE 16 0.0011
469 HIP ARTHROPLASTY 17 0.0011
470 PAIN IN EXTREMITY 327 0.0011
471 BLADDER DISORDER 11 0.0011
472 FAECES SOFT 8 0.0011
473 SEIZURE 127 0.0011
474 WEIGHT INCREASED 246 0.0011
475 OESOPHAGITIS 12 0.0011
476 ATAXIA 13 0.0011
477 LETHARGY 63 0.0011
478 ESCHERICHIA INFECTION 9 0.0011
479 ANGER 37 0.0011
480 CORONARY ARTERY OCCLUSION 15 0.0011
481 LOWER LIMB FRACTURE 21 0.0011
482 BLOOD PRESSURE INCREASED 167 0.0011
483 STAPHYLOCOCCAL INFECTION 36 0.0011
484 FOETAL EXPOSURE DURING PREGNANCY 88 0.0011
485 FLUSHING 110 0.0011
486 PROCEDURAL PAIN 30 0.0011
487 PRODUCT USE COMPLAINT 17 0.0011
488 DEPRESSED MOOD 57 0.0011
489 CONSTIPATION 235 0.0011
490 EUPHORIC MOOD 11 0.0011
491 THROAT TIGHTNESS 29 0.0011
492 NOCTURIA 13 0.0011
493 MENORRHAGIA 21 0.0011
494 SEDATION 28 0.0011
495 ULCER 17 0.0011
496 CHILLS 125 0.0011
497 DYSPHAGIA 101 0.0011
498 ORAL CANDIDIASIS 14 0.0011
499 HYPERTENSION 225 0.0011
500 DYSPNOEA EXERTIONAL 40 0.0011
501 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
502 PANCREATITIS 56 0.0011
503 HAEMATOCRIT DECREASED 21 0.0011
504 FATIGUE 822 0.0011
505 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
506 BLOOD URINE PRESENT 20 0.0011
507 INTENTIONAL DRUG MISUSE 22 0.0011
508 RESPIRATORY DISTRESS 29 0.0010
509 SUBDURAL HAEMATOMA 15 0.0010
510 IRRITABILITY 63 0.0010
511 INCREASED APPETITE 20 0.0010
512 QUALITY OF LIFE DECREASED 14 0.0010
513 PRODUCT TASTE ABNORMAL 14 0.0010
514 ERUCTATION 20 0.0010
515 TENDONITIS 16 0.0010
516 MANIA 17 0.0010
517 LOCAL SWELLING 18 0.0010
518 UNEVALUABLE EVENT 78 0.0010
519 BLINDNESS 42 0.0010
520 URINE OUTPUT DECREASED 9 0.0010
521 PRESYNCOPE 25 0.0010
522 DYSPHONIA 60 0.0010
523 HEART RATE DECREASED 36 0.0010
524 THERAPY NON-RESPONDER 46 0.0010
525 HOT FLUSH 77 0.0010
526 GASTRIC DISORDER 35 0.0010
527 NEUROPATHY PERIPHERAL 97 0.0010
528 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
529 WRONG TECHNIQUE IN DRUG USAGE PROCESS 37 0.0010
530 LYMPHADENOPATHY 36 0.0010
531 KNEE OPERATION 10 0.0010
532 COVID-19 PNEUMONIA 12 0.0010
533 DRY MOUTH 82 0.0010
534 ABDOMINAL PAIN 235 0.0010
535 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
536 TYPE 2 DIABETES MELLITUS 34 0.0010
537 EMBEDDED DEVICE 10 0.0010
538 BLOOD ALBUMIN DECREASED 8 0.0010
539 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
540 SUICIDE ATTEMPT 61 0.0010
541 PREGNANCY WITH CONTRACEPTIVE DEVICE 9 0.0010
542 PHARMACEUTICAL PRODUCT COMPLAINT 26 0.0010
543 OEDEMA 54 0.0010
544 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
545 ABDOMINAL PAIN LOWER 25 0.0010
546 DECREASED APPETITE 229 0.0010
547 COUGH 276 0.0010
548 NO THERAPEUTIC RESPONSE 12 0.0010
549 MYALGIA 167 0.0010
550 DEHYDRATION 131 0.0010
551 SUBARACHNOID HAEMORRHAGE 10 0.0010
552 MUSCULOSKELETAL STIFFNESS 86 0.0010
553 DRY EYE 49 0.0010
554 BRAIN NEOPLASM 9 0.0010
555 RED BLOOD CELL COUNT DECREASED 28 0.0010
556 WITHDRAWAL SYNDROME 41 0.0010
557 EYE HAEMORRHAGE 13 0.0010
558 HEART RATE IRREGULAR 22 0.0010
559 VOMITING 457 0.0010
560 FEELING COLD 27 0.0010
561 THROMBOSIS 78 0.0010
562 HEART RATE INCREASED 96 0.0010
563 PERSONALITY CHANGE 9 0.0010
564 ABDOMINAL DISTENSION 101 0.0010
565 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
566 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
567 PRODUCTIVE COUGH 46 0.0010
568 TOXICITY TO VARIOUS AGENTS 162 0.0010
569 FLANK PAIN 9 0.0010
570 CONFUSIONAL STATE 155 0.0010
571 BLOOD PRESSURE FLUCTUATION 23 0.0010
572 CYANOSIS 15 0.0010
573 LEUKAEMIA 9 0.0010
574 ALOPECIA 187 0.0010
575 PERICARDIAL EFFUSION 22 0.0010
576 LOCALISED INFECTION 23 0.0010
577 BRAIN OEDEMA 12 0.0009
578 SPUTUM DISCOLOURED 9 0.0009
579 FEELING HOT 58 0.0009
580 GAIT DISTURBANCE 181 0.0009
581 RESPIRATORY ARREST 26 0.0009
582 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
583 ABNORMAL DREAMS 26 0.0009
584 IMMUNODEFICIENCY 14 0.0009
585 OSTEOMYELITIS 17 0.0009
586 HYPOXIA 33 0.0009
587 ACUTE RESPIRATORY FAILURE 18 0.0009
588 UNRESPONSIVE TO STIMULI 24 0.0009
589 BLOOD TEST ABNORMAL 13 0.0009
590 CHOKING 18 0.0009
591 EYE PAIN 52 0.0009
592 COELIAC DISEASE 9 0.0009
593 GASTROINTESTINAL DISORDER 82 0.0009
594 HEPATIC STEATOSIS 17 0.0009
595 EYE DISORDER 30 0.0009
596 DRUG ADMINISTRATION ERROR 28 0.0009
597 NASOPHARYNGITIS 168 0.0009
598 EPISTAXIS 68 0.0009
599 DISORIENTATION 36 0.0009
600 THYROID DISORDER 14 0.0009
601 LUNG INFECTION 14 0.0009
602 BURNING SENSATION 63 0.0009
603 SPINAL FRACTURE 18 0.0009
604 HYPERTHYROIDISM 13 0.0009
605 THERAPY PARTIAL RESPONDER 14 0.0009
606 NERVOUS SYSTEM DISORDER 28 0.0009
607 INJECTION SITE HAEMATOMA 13 0.0009
608 HYPOKINESIA 13 0.0009
609 MUSCLE SPASTICITY 11 0.0009
610 OEDEMA PERIPHERAL 109 0.0009
611 DIARRHOEA 576 0.0009
612 ANAL INCONTINENCE 8 0.0009
613 ASTHENIA 334 0.0009
614 VISUAL IMPAIRMENT 110 0.0009
615 HERPES ZOSTER 51 0.0009
616 MALAISE 388 0.0009
617 MOTOR DYSFUNCTION 9 0.0009
618 ABDOMINAL DISCOMFORT 148 0.0009
619 DRUG EFFECT INCOMPLETE 32 0.0009
620 INJECTION SITE RASH 27 0.0009
621 PRESCRIBED OVERDOSE 17 0.0009
622 SCAB 10 0.0009
623 DYSTONIA 17 0.0009
624 DEVICE DISLOCATION 38 0.0009
625 ARTHRALGIA 363 0.0009
626 DRUG EFFECT DECREASED 47 0.0009
627 COLITIS 33 0.0009
628 SYNCOPE 87 0.0009
629 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
630 INTENTIONAL PRODUCT USE ISSUE 76 0.0009
631 DYSGEUSIA 64 0.0009
632 PRODUCT ODOUR ABNORMAL 9 0.0009
633 DRUG DOSE OMISSION 142 0.0009
634 BLOOD PRESSURE DECREASED 57 0.0009
635 ENCEPHALOPATHY 21 0.0009
636 PRESCRIBED UNDERDOSE 17 0.0009
637 FULL BLOOD COUNT ABNORMAL 9 0.0009
638 PERIPHERAL SWELLING 131 0.0008
639 RESPIRATORY FAILURE 62 0.0008
640 ABASIA 21 0.0008
641 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
642 SKIN DISCOLOURATION 39 0.0008
643 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
644 ARTHROPATHY 47 0.0008
645 AGITATION 62 0.0008
646 CEREBROVASCULAR ACCIDENT 143 0.0008
647 DYSURIA 31 0.0008
648 MATERNAL EXPOSURE DURING PREGNANCY 75 0.0008
649 MUSCULOSKELETAL DISORDER 16 0.0008
650 MYOCLONUS 10 0.0008
651 COVID-19 147 0.0008
652 ABNORMAL BEHAVIOUR 33 0.0008
653 FAECES DISCOLOURED 18 0.0008
654 HYPERSENSITIVITY 154 0.0008
655 BRAIN FOG 13 0.0008
656 VAGINAL HAEMORRHAGE 36 0.0008
657 LEUKOCYTOSIS 15 0.0008
658 PRODUCT DOSE OMISSION 54 0.0008
659 AUTOIMMUNE DISORDER 8 0.0008
660 ACCIDENTAL OVERDOSE 30 0.0008
661 COMA 39 0.0008
662 HALLUCINATION, AUDITORY 13 0.0008
663 URTICARIA 137 0.0008
664 MOOD SWINGS 26 0.0008
665 VISUAL ACUITY REDUCED 27 0.0008
666 CARDIOMYOPATHY 12 0.0008
667 RASH PRURITIC 44 0.0008
668 INABILITY TO AFFORD MEDICATION 8 0.0008
669 DYSPNOEA 452 0.0008
670 CHROMATURIA 18 0.0008
671 IMPAIRED WORK ABILITY 17 0.0008
672 SLEEP DISORDER 56 0.0008
673 APPLICATION SITE PRURITUS 18 0.0008
674 CORONARY ARTERY DISEASE 24 0.0008
675 LYMPHOCYTE COUNT DECREASED 14 0.0008
676 POLLAKIURIA 33 0.0008
677 INJECTION SITE PRURITUS 53 0.0008
678 ACUTE KIDNEY INJURY 121 0.0008
679 HAEMOPTYSIS 22 0.0008
680 INTERNAL HAEMORRHAGE 9 0.0008
681 SWELLING FACE 51 0.0008
682 PHARYNGEAL OEDEMA 12 0.0008
683 HAEMATOCHEZIA 43 0.0008
684 MOVEMENT DISORDER 25 0.0008
685 GAIT INABILITY 26 0.0008
686 GENITAL HAEMORRHAGE 10 0.0008
687 ANOREXIA 10 0.0008
688 MUSCULOSKELETAL CHEST PAIN 12 0.0008
689 PNEUMONIA 251 0.0008
690 ELECTROLYTE IMBALANCE 9 0.0008
691 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
692 INTENTIONAL DOSE OMISSION 22 0.0008
693 INJECTION SITE INDURATION 10 0.0008
694 INTESTINAL OBSTRUCTION 29 0.0008
695 HAEMOGLOBIN DECREASED 79 0.0008
696 PRODUCT DOSE OMISSION ISSUE 226 0.0008
697 ORAL HERPES 15 0.0008
698 SPINAL PAIN 9 0.0008
699 SEXUAL DYSFUNCTION 9 0.0008
700 NODULE 10 0.0008
701 KIDNEY INFECTION 15 0.0008
702 APPLICATION SITE ERYTHEMA 20 0.0008
703 METRORRHAGIA 13 0.0008
704 IMPAIRED HEALING 25 0.0008
705 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
706 RHINORRHOEA 49 0.0008
707 INJECTION SITE MASS 28 0.0008
708 PNEUMOTHORAX 12 0.0008
709 LIVER FUNCTION TEST ABNORMAL 22 0.0008
710 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
711 DISCOMFORT 46 0.0008
712 MACULAR DEGENERATION 9 0.0008
713 ANAEMIA 143 0.0007
714 PRODUCT SUBSTITUTION ISSUE 43 0.0007
715 ORTHOSTATIC HYPOTENSION 13 0.0007
716 HEPATITIS C 9 0.0007
717 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
718 RECTAL HAEMORRHAGE 32 0.0007
719 INJECTION SITE PAIN 228 0.0007
720 HYPOPHAGIA 19 0.0007
721 HALLUCINATION 56 0.0007
722 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
723 CONDITION AGGRAVATED 224 0.0007
724 SWOLLEN TONGUE 23 0.0007
725 RESPIRATORY DISORDER 22 0.0007
726 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
727 DRUG TOXICITY 10 0.0007
728 INTENTIONAL PRODUCT MISUSE 64 0.0007
729 MULTIPLE FRACTURES 12 0.0007
730 OXYGEN SATURATION DECREASED 41 0.0007
731 DRUG WITHDRAWAL SYNDROME 64 0.0007
732 INJECTION SITE WARMTH 15 0.0007
733 PHOTOSENSITIVITY REACTION 12 0.0007
734 EYE SWELLING 27 0.0007
735 BLOOD COUNT ABNORMAL 11 0.0007
736 INFECTION 105 0.0007
737 WHEEZING 43 0.0007
738 DRUG LEVEL INCREASED 12 0.0007
739 GOUT 13 0.0007
740 INFUSION RELATED REACTION 48 0.0007
741 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
742 DEVICE FAILURE 11 0.0007
743 DRUG DISPENSING ERROR 11 0.0007
744 TOOTH DISORDER 16 0.0007
745 HIP FRACTURE 23 0.0007
746 RASH PAPULAR 16 0.0007
747 DEVICE OCCLUSION 10 0.0007
748 HALLUCINATION, VISUAL 15 0.0007
749 TARDIVE DYSKINESIA 20 0.0007
750 BLOOD GLUCOSE DECREASED 34 0.0007
751 INJECTION SITE IRRITATION 9 0.0007
752 FLATULENCE 40 0.0007
753 EATING DISORDER 15 0.0007
754 HEPATIC ENZYME INCREASED 48 0.0007
755 BLOOD GLUCOSE ABNORMAL 13 0.0007
756 PYREXIA 243 0.0007
757 INJECTION SITE BRUISING 56 0.0007
758 CONJUNCTIVITIS 13 0.0007
759 PREGNANCY 14 0.0007
760 HYPOTENSION 140 0.0007
761 HAEMATOMA 18 0.0007
762 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
763 THERAPEUTIC PRODUCT EFFECT DECREASED 31 0.0007
764 PRODUCT QUALITY ISSUE 94 0.0007
765 OVERDOSE 149 0.0007
766 PRODUCT DISPENSING ERROR 15 0.0007
767 EYELID OEDEMA 8 0.0007
768 RENAL FAILURE 91 0.0007
769 MOBILITY DECREASED 49 0.0007
770 AGEUSIA 17 0.0007
771 COLD SWEAT 12 0.0007
772 LABORATORY TEST ABNORMAL 20 0.0007
773 GLAUCOMA 13 0.0007
774 SKIN HAEMORRHAGE 10 0.0007
775 HERNIA 13 0.0007
776 CATARACT 40 0.0007
777 RASH ERYTHEMATOUS 32 0.0007
778 HAEMORRHAGE INTRACRANIAL 10 0.0007
779 MOUTH ULCERATION 14 0.0007
780 INJECTION SITE HAEMORRHAGE 53 0.0007
781 TACHYPNOEA 9 0.0007
782 LIP SWELLING 22 0.0007
783 AKATHISIA 9 0.0007
784 DRUG INEFFECTIVE 868 0.0007
785 BLOOD UREA INCREASED 11 0.0007
786 INJECTION SITE SWELLING 50 0.0007
787 CARDIAC DISORDER 61 0.0007
788 HYPERCALCAEMIA 8 0.0006
789 HYPOMAGNESAEMIA 9 0.0006
790 COORDINATION ABNORMAL 9 0.0006
791 ACUTE MYOCARDIAL INFARCTION 19 0.0006
792 WOUND 18 0.0006
793 PRODUCT ADHESION ISSUE 23 0.0006
794 PRODUCT ADMINISTRATION ERROR 13 0.0006
795 TASTE DISORDER 13 0.0006
796 OSTEONECROSIS 21 0.0006
797 SKIN REACTION 9 0.0006
798 INJURY ASSOCIATED WITH DEVICE 13 0.0006
799 PARANOIA 11 0.0006
800 NIGHTMARE 22 0.0006
801 APPLICATION SITE PAIN 14 0.0006
802 HYPERGLYCAEMIA 23 0.0006
803 STEVENS-JOHNSON SYNDROME 14 0.0006
804 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 113 0.0006
805 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 127 0.0006
806 INJECTION SITE REACTION 43 0.0006
807 ABORTION SPONTANEOUS 25 0.0006
808 SENSORY DISTURBANCE 10 0.0006
809 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
810 KNEE ARTHROPLASTY 13 0.0006
811 CEREBRAL HAEMORRHAGE 22 0.0006
812 FEMUR FRACTURE 19 0.0006
813 PLATELET COUNT DECREASED 65 0.0006
814 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
815 LIVER FUNCTION TEST INCREASED 13 0.0006
816 TREATMENT NONCOMPLIANCE 33 0.0006
817 COMPLICATION OF DEVICE INSERTION 12 0.0006
818 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
819 RESTLESSNESS 22 0.0006
820 BONE LOSS 9 0.0006
821 PRURITUS 228 0.0006
822 HAEMATEMESIS 15 0.0006
823 DEVICE ISSUE 53 0.0006
824 PRODUCT USE ISSUE 111 0.0006
825 DIABETES MELLITUS 45 0.0006
826 EPILEPSY 18 0.0006
827 BODY TEMPERATURE INCREASED 12 0.0006
828 HEPATIC CIRRHOSIS 11 0.0006
829 HYPOKALAEMIA 27 0.0006
830 DEVICE RELATED INFECTION 9 0.0006
831 TRANSAMINASES INCREASED 13 0.0006
832 DRUG DEPENDENCE 94 0.0006
833 APPLICATION SITE RASH 8 0.0006
834 INFLAMMATION 30 0.0006
835 INJECTION SITE ERYTHEMA 72 0.0006
836 JOINT SWELLING 70 0.0006
837 RENAL DISORDER 27 0.0006
838 RASH GENERALISED 15 0.0006
839 ANAPHYLACTIC REACTION 32 0.0006
840 EJECTION FRACTION DECREASED 9 0.0006
841 PANCREATITIS ACUTE 13 0.0006
842 BASAL CELL CARCINOMA 9 0.0006
843 DRUG ABUSE 48 0.0006
844 BONE DENSITY DECREASED 18 0.0006
845 TACHYCARDIA 51 0.0006
846 PULMONARY FIBROSIS 11 0.0006
847 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
848 EXPIRED PRODUCT ADMINISTERED 19 0.0006
849 LUNG DISORDER 28 0.0006
850 BLINDNESS UNILATERAL 8 0.0006
851 EXTRAPYRAMIDAL DISORDER 14 0.0006
852 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
853 STOMATITIS 34 0.0006
854 PAIN OF SKIN 15 0.0006
855 SEPSIS 62 0.0006
856 BLOOD POTASSIUM INCREASED 9 0.0006
857 ANOSMIA 8 0.0006
858 DRUG INTOLERANCE 53 0.0005
859 CYTOKINE RELEASE SYNDROME 11 0.0005
860 RASH 239 0.0005
861 GASTROENTERITIS 8 0.0005
862 HEPATITIS 14 0.0005
863 FULL BLOOD COUNT DECREASED 11 0.0005
864 INTENTIONAL OVERDOSE 35 0.0005
865 THERAPEUTIC RESPONSE DECREASED 33 0.0005
866 PLEURAL EFFUSION 33 0.0005
867 LIVER DISORDER 24 0.0005
868 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
869 URINARY RETENTION 18 0.0005
870 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
871 GLOSSODYNIA 12 0.0005
872 PERICARDITIS 9 0.0005
873 JOINT STIFFNESS 14 0.0005
874 LACRIMATION INCREASED 16 0.0005
875 DEVICE DIFFICULT TO USE 35 0.0005
876 HYPOCALCAEMIA 10 0.0005
877 HAEMORRHAGE 55 0.0005
878 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
879 ATRIAL FIBRILLATION 51 0.0005
880 ADVERSE DRUG REACTION 47 0.0005
881 CARDIAC FAILURE CONGESTIVE 42 0.0005
882 MENSTRUATION IRREGULAR 14 0.0005
883 SHOCK 12 0.0005
884 MYOCARDIAL INFARCTION 91 0.0005
885 DRUG PRESCRIBING ERROR 10 0.0005
886 PNEUMONIA ASPIRATION 13 0.0005
887 RHEUMATOID ARTHRITIS 59 0.0005
888 AGGRESSION 26 0.0005
889 HYPOGLYCAEMIA 25 0.0005
890 NEUTROPHIL COUNT DECREASED 21 0.0005
891 DEPENDENCE 28 0.0005
892 DRUG INTERACTION 81 0.0005
893 SKIN DISORDER 17 0.0005
894 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
895 LOWER RESPIRATORY TRACT INFECTION 23 0.0005
896 SKIN ULCER 13 0.0005
897 ABSCESS 8 0.0005
898 RENAL IMPAIRMENT 42 0.0005
899 DIABETIC KETOACIDOSIS 12 0.0005
900 RENAL FAILURE ACUTE 21 0.0005
901 ILL-DEFINED DISORDER 30 0.0005
902 PULMONARY OEDEMA 22 0.0005
903 ADVERSE EVENT 45 0.0005
904 PRODUCT AVAILABILITY ISSUE 11 0.0005
905 TOOTH LOSS 10 0.0005
906 HOSPITALISATION 74 0.0005
907 BLISTER 27 0.0005
908 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
909 THERAPY INTERRUPTED 34 0.0005
910 DEVICE MALFUNCTION 33 0.0005
911 THERAPY CESSATION 24 0.0005
912 HYPOACUSIS 20 0.0005
913 SKIN IRRITATION 21 0.0005
914 RASH MACULAR 16 0.0005
915 DEVICE USE ISSUE 8 0.0005
916 THROMBOCYTOPENIA 51 0.0005
917 PRODUCT USE IN UNAPPROVED INDICATION 113 0.0005
918 CEREBRAL INFARCTION 11 0.0004
919 CARDIAC ARREST 37 0.0004
920 LIVER INJURY 11 0.0004
921 ERYTHEMA 92 0.0004
922 EXTRA DOSE ADMINISTERED 18 0.0004
923 FREQUENT BOWEL MOVEMENTS 12 0.0004
924 ARRHYTHMIA 21 0.0004
925 DEVICE BREAKAGE 18 0.0004
926 ASCITES 13 0.0004
927 RENAL INJURY 13 0.0004
928 EYE IRRITATION 25 0.0004
929 BRADYCARDIA 23 0.0004
930 BLOOD CREATININE INCREASED 28 0.0004
931 HYPONATRAEMIA 24 0.0004
932 UNDERDOSE 31 0.0004
933 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
934 SKIN CANCER 9 0.0004
935 ACCIDENTAL EXPOSURE TO PRODUCT 43 0.0004
936 PSYCHOTIC DISORDER 12 0.0004
937 PALLOR 11 0.0004
938 DELIRIUM 14 0.0004
939 CARDIAC FAILURE 32 0.0004
940 INCORRECT DOSE ADMINISTERED 90 0.0004
941 DEMENTIA 11 0.0004
942 ANGINA PECTORIS 11 0.0004
943 RHABDOMYOLYSIS 16 0.0004
944 PSORIASIS 50 0.0004
945 LEUKOPENIA 19 0.0004
946 HAEMATURIA 13 0.0004
947 OFF LABEL USE 332 0.0004
948 BREAST CANCER 35 0.0004
949 DEVICE LEAKAGE 16 0.0004
950 HEPATIC FAILURE 11 0.0004
951 SKIN LESION 10 0.0004
952 OSTEONECROSIS OF JAW 9 0.0004
953 DRY SKIN 48 0.0004
954 OCULAR HYPERAEMIA 17 0.0004
955 DISEASE RECURRENCE 17 0.0004
956 BLOOD GLUCOSE INCREASED 66 0.0003
957 DEVICE USE ERROR 12 0.0003
958 PSORIATIC ARTHROPATHY 14 0.0003
959 MEDICATION ERROR 19 0.0003
960 ANGIOEDEMA 15 0.0003
961 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
962 DEATH 287 0.0003
963 PNEUMONITIS 9 0.0003
964 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
965 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
966 ANAPHYLACTIC SHOCK 8 0.0003
967 BREAST CANCER FEMALE 8 0.0003
968 EYE PRURITUS 10 0.0003
969 SKIN EXFOLIATION 25 0.0003
970 BLOOD BILIRUBIN INCREASED 8 0.0003
971 DISEASE PROGRESSION 35 0.0003
972 COLITIS ULCERATIVE 13 0.0003
973 INTERSTITIAL LUNG DISEASE 13 0.0003
974 PANCYTOPENIA 15 0.0003
975 NEOPLASM PROGRESSION 9 0.0003
976 NEOPLASM MALIGNANT 17 0.0003
977 ACNE 19 0.0003
978 HYPERKALAEMIA 8 0.0002
979 DERMATITIS ATOPIC 12 0.0002
980 LUNG NEOPLASM MALIGNANT 9 0.0002
981 FEBRILE NEUTROPENIA 14 0.0002
982 NEUTROPENIA 27 0.0002
983 PRODUCT STORAGE ERROR 17 0.0002
984 ECZEMA 10 0.0002
985 DEVICE EXPULSION 12 0.0002
986 TREATMENT FAILURE 15 0.0002
987 NO ADVERSE EVENT 32 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
989 SKIN BURNING SENSATION 11 0.0002
990 DRUG DOSE OMISSION BY DEVICE 10 0.0001